ADVERTISEMENT

Stay up to date every week with the european biotechnology newsletter.

✕
This field is hidden when viewing the form
EBcom NL
This field is hidden when viewing the form
Consent
This field is for validation purposes and should be left unchanged.

Stay up to date every week with the european biotechnology newsletter.

Log in here to read the desired article.

This field is hidden when viewing the form
EBcom NL
This field is hidden when viewing the form
Consent
This field is for validation purposes and should be left unchanged.
go to the article

go back to the homepage

  • BIOCOM CARD
  • Newsletter
  • Advertising
  • Job Market
  • Shop
European Biotechnology Magazine
biocom_logo
  • Latest news
  • Background
  • Opinion
  • The Mag
    • Issues
    • Special
    • Subscribe
  • Euro Biotech Guide
  • Market Place
    • Products
    • Sponsored Publications
    • Advertise
  • Associations
  • Service
    • Job Market
    • Newsletter
    • Contact Us
    • Editorial Team
  • Events
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu
CAR-T cell therapy

A Universal Solution Emerges: Anti-Linker Antibodies Simplify CAR-T Detection and Development

CAR-T cell therapy has demonstrated remarkable success in treating hematologic malignancies and is now expanding into solid tumors. On June 1, 2025, The Lancet published positive results from the world’s first randomized controlled trial of CLDN18.2 specific CAR-T in gastric cancer, led … more ➔

LATEST NEWS

Roche towers in BaselHenk Vrieselaar - stock.adobe.com

Roche acquires 89bio for US$3.5bn

Thrombosis under electron microscopeAdobe stock photos - nadia

CSL backs VarmX in US$2.2bn deal

DNA Helixadobe stock photos - kemol

Enhanced Genomics raises US$19m

ADVERTISEMENT

MAGAZINE

1 / 4
01_EB225_Titel.indd

This issue focuses on the art of upscaling industrial biotechnology in Europe, the impact of the Trump factor on the life sciences and the European Commission's new billion-euro fund for emerging … more ➔

2 / 4
EB125_Cover

This issue offers insights into Europe's fight for green solutions for a bioeconomy, antimicrobial resistance and how Europe is preparing for the next pandemic. more ➔

3 / 4
EB424_Cover

Since the first antibody drug was approved back in 1986, monoclonal antibodies have emerged as the dominant class in the global US$417bn market for biologics. At the end of 2023, sales stood at more … more ➔

4 / 4
EB324_Titel

The first half of 2024 is history, and experts are divided on whether the financing nadir has been reached or even passed. There are very different figures for different types of treatments under … more ➔

SPONSORED PUBLICATION

Messegeschehen / Trade fair activity
POWTECH TECHNOPHARM

About POWTECH TECHNOPHARM

POWTECH TECHNOPHARM (Nuremberg, 23-25 September 2025) is the international trade fair for process engineering experts and a tailor-made technology platform for the pharmaceutical and life science … more ➔

newsletter_link
© BIOCOM Interrelations GmbH
  • Link to LinkedIn
  • Link to Instagram
  • Contact
  • Imprint
  • Privacy policy
Scroll to top Scroll to top Scroll to top